$41.200
-2.464 (-5.98%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de IMVT por análisis de gráficos similares
Alphio's IMVT stock price prediction model matches the current Immunovant Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $42.06 (+2.08%). The 1-week path is $42.94 (+4.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Immunovant Inc?
Immunovant Inc is a good buy right now due to its recent positive clinical trial results showing a 72.7% improvement rate in patients, which significantly boosts its growth potential. The stock is currently priced at $41.20, well below the analyst price target of $50 from JPMorgan, indicating a substantial upside. However, investors should be cautious of the company's ongoing high net losses, which reached $147.9 million in the last quarter, representing a risk to short-term performance.
IMVT cerró en $41.20 el Friday, tras bajar -5.98%
Immunovant Inc (IMVT) last closed at $41.2, losing -5.98%. These facts feed the 1-day and 1-week IMVT price prediction above.
Factores de la previsión
Los factores de la previsión de Immunovant Inc (IMVT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de IMVT, ordenadas por similitud.
Análisis de estacionalidad de IMVT
Historically the probability of a positive August return for IMVT is 31.75%. January offers the highest probability of a positive month at 37.70%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de IMVT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $20.74 | $21.53 | $22.42 | -47.74% |
| Sep 2026 | $19.49 | $21.63 | $24.77 | -47.51% |
| Oct 2026 | $11.99 | $15.98 | $17.74 | -61.20% |
| Nov 2026 | $12.10 | $15.98 | $17.52 | -61.20% |
| Dec 2026 | $11.48 | $15.98 | $16.79 | -61.20% |
En 2026, se proyecta que Immunovant Inc (IMVT) oscile entre $11.48 y $24.77.
Previsión mensual de Immunovant Inc para 2026
En Aug de 2026, se proyecta que Immunovant Inc promedie $21.53, con un mínimo de $20.74 y un máximo de $22.42.
En Sep de 2026, se proyecta que Immunovant Inc promedie $21.63, con un mínimo de $19.49 y un máximo de $24.77.
En Oct de 2026, se proyecta que Immunovant Inc promedie $15.98, con un mínimo de $11.99 y un máximo de $17.74.
En Nov de 2026, se proyecta que Immunovant Inc promedie $15.98, con un mínimo de $12.10 y un máximo de $17.52.
En Dec de 2026, se proyecta que Immunovant Inc promedie $15.98, con un mínimo de $11.48 y un máximo de $16.79.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.